Tag: CBT > Cannabis Pharmaceutical Drug

Canadian Cannabis Market

HYTN Secures Cannabis Drug License, Advancing Pathway for Prescription Cannabinoid-Based Medicines

The company is authorized to manufacture cannabis-derived pharmaceutical drugs in Canada.

July 14, 2025

Industry Headlines

DeFloria Receives Investigational New Drug Application Clearance From FDA for Cannabinoid Drug to Treat Autism Spectrum Disorder

DeFloria plans to initiate a Phase 2 clinical trial by mid-year 2025.

February 24, 2025

Industry Headlines

Avextra Portugal Unveils Advanced Breeding Program to Develop Proprietary THC and CBD Cultivars, Establishing a Key IP Pillar

Led by industry experts, including former GW Pharmaceuticals Director Alan Sutton and genetics and cultivation expert Steven Tan, the program focuses on breeding proprietary plants that are ideal for clinical research and pharmaceutical production.

November 29, 2024

Cannabis Advertising

The Complex Impact of Rescheduling Cannabis on Advertising

The penalties for advertising Schedule I drugs don’t apply to Schedule III drugs, but cannabis businesses could be left in a precarious position.

September 17, 2024

Industry Headlines

MMJ BioPharma Suing DEA Over Cannabis Reform, Medical Research

The biopharmaceutical company filed a lawsuit, citing ‘unjustified’ delays in processing an application for medical research.

September 11, 2024

Industry Headlines

HYTN Awarded Drug Establishment License from Health Canada, Able to Export Cannabis Pharmaceutical Products Globally

HYTN Innovations Inc., a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis and psilocybin, announces that it has been granted a Drug Establishment License (DEL) by Health Canada.

June 27, 2024

Industry Headlines

Avextra AG and SynQube GmbH Announce a Strategic Partnership in Drug Development With Cannabinoids and Other Psychotropic Substances

June 20, 2024

International

Jamaica Company Ships 1st Legal Exports of THC to United States For DEA Testing

Pure Jamaican elevates Jamaica as a global provider of legal cannabis with pharmaceutical THC product exports to the U.S. and Brazil.

February 22, 2024

Outdoor Cannabis Cultivation

The Pharma Flip

Disenchanted after decades in the pharmaceutical industry, Jason Neely and Brenda Verghese pivoted to cannabis, harnessing their formulation experience to put health and consistency at the forefront of Stratos.

August 10, 2022

International

Khiron to Acquire EU-GMP-Certified German Pharmaceuticals Manufacturer and Wholesaler, Expanding its European Footprint

This acquisition will accelerate Khiron's growth in Europe by controlling the complete value chain for its products and gaining direct access to German pharmacies.

May 31, 2022

Utah

Pfizer Enters $6.7-Billion Acquisition Deal With Cannabis Pipeline

The American multinational pharmaceutical and biotechnology company signed an agreement with clinical-stage company Arena Pharmaceuticals.

December 21, 2021

CO2 Extraction

Beyond Bag Appeal

Growers pride themselves on their bud’s appearance, but markets exist for cannabis products that don’t necessarily catch the eye.

November 29, 2021